Skip to main content

Animations

MJFF Publications

3521 - 3530 of 6230 Results
Title
Year
  • Year
  • 2020
  • 2019
  • 2017
  • 2025
  • 2019
  • 2024
  • 2022
  • 2025
  • 2016
  • 2019
  • Summary Details
    OPEN
    Title: Prevalence of GBA p.K198E mutation in Colombian and Hispanic populations
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.03.008
    Citation Count: 7
  • Summary Details
    OPEN
    Title: Investigation of somatic CNVs in brains of synucleinopathy cases using targeted SNCA analysis and single cell sequencing
    Journal Name: Acta Neuropathologica Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s40478-019-0873-5
    Citation Count: 41
  • Summary Details
    OPEN
    Title: Normative morphometric data for cerebral cortical areas over the lifetime of the adult human brain
    Journal Name: NeuroImage
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: other-oa
    DOI - Digital Object Identifier: 10.1016/j.neuroimage.2017.05.019
    Citation Count: 78
  • Summary Details
    OPEN
    Title: Parkinson’s disease is characterized by vitamin B6-dependent inflammatory kynurenine pathway dysfunction
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-025-00964-7
    Citation Count: 1
  • Summary Details
    OPEN
    Title: SNCAandmTORPathway Single Nucleotide Polymorphisms Interact to Modulate the Age at Onset of Parkinson's Disease
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.27770
    Citation Count: 24
  • Summary Details
    OPEN
    Title: In Silico Investigation of Parkin-Activating Mutations Using Simulations and Network Modeling
    Journal Name: Biomolecules
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/biom14030365
    Citation Count: 4
  • Summary Details
    OPEN
    Title: Combining biomarkers for prognostic modelling of Parkinson’s disease
    Journal Name: Journal of Neurology, Neurosurgery & Psychiatry
    Publisher: BMJ
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1136/jnnp-2021-328365
    Citation Count: 23
  • Summary Details
    OPEN
    Title: LRRK2-associated parkinsonism with and without in vivo evidence of alpha-synuclein aggregates: longitudinal clinical and biomarker characterization
    Journal Name: Brain Communications
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1093/braincomms/fcaf103
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Structural model of the dimeric Parkinson’s protein LRRK2 reveals a compact architecture involving distant interdomain contacts
    Journal Name: Proceedings of the National Academy of Sciences
    Publisher: Proceedings of the National Academy of Sciences
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1073/pnas.1523708113
    Citation Count: 147
  • Summary Details
    OPEN
    Title: Higher Urine bis(Monoacylglycerol)Phosphate Levels in LRRK2 G2019S Mutation Carriers: Implications for Therapeutic Development
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/mds.27818
    Citation Count: 69
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.